News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Mar / 2026

March 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

« Feb

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Tedros Adhanom Ghebreyesus: Peace is the Best Medicine

Tedros Adhanom Ghebreyesus: Peace is the Best Medicine

Kevin Harrington: The Institute of Cancer Research Received The Queen Elizabeth Prize

Kevin Harrington: The Institute of Cancer Research Received The Queen Elizabeth Prize

Top 10 Colorectal Cancer Updates – February 2026

Top 10 Colorectal Cancer Updates – February 2026

John Leonard on Combining CHOP and Anti-CD20 Therapy in Lymphoma

John Leonard on Combining CHOP and Anti-CD20 Therapy in Lymphoma

Patrick Soon-Shiong: Anktiva Plus Keytruda Shows Potential to Prolong Survival in Patients with Lung Cancer

Patrick Soon-Shiong: Anktiva Plus Keytruda Shows Potential to Prolong Survival in Patients with Lung Cancer

How I Treat Gallbladder and Bile Duct Cancer in 2026: OncoDaily Virtual Summit

How I Treat Gallbladder and Bile Duct Cancer in 2026: OncoDaily Virtual Summit

Lonny Yarmus: Beginning a New Leadership Chapter at Memorial Sloan Kettering Cancer Center

Lonny Yarmus: Beginning a New Leadership Chapter at Memorial Sloan Kettering Cancer Center

United by Unique: Turning a Powerful Message into Meaningful Action - CancerWorld

United by Unique: Turning a Powerful Message into Meaningful Action - CancerWorld

𝐈𝐦𝐦𝐮𝐧𝐨𝐝𝐞𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲

Mar 20, 2024 1:08 pm

Insight

St. Anna Children’s Cancer Research Institute (CCRI) is investigating how endoplasmic reticulum is linked to a newly discovered immunodeficiency

St. Anna Children’s Cancer Research Institute (CCRI) is investigating how endoplasmic reticulum is linked to a newly discovered immunodeficiency

Dec 30, 2023 4:09 am

Oncology Drugs

Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area

Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area

Headlines

Hope Rugo: Practice-Changing Data in High-Risk HER2+ ESBC

Full House Star Dave Coulier Overcomes Two Separate Cancers, a Story of Early Detection and Survival

WHO Warns Europe to Remain World’s Tobacco Epicenter by 2030

Zongertinib Receives FDA Accelerated Approval in HER2-Mutant NSCLC

Vir–Astellas Prostate Cancer Deal and ALX Oncology’s 2025 Results Set 2026 Catalysts

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research ASCO24 colorectal cancer Childhood Cancer clinical trials prostate cancer FDA AACR UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Myeloma Robert Orlowski NCI Vivek Subbiah National Cancer Institute American Society of Clinical Oncology Myeloma Paper of the Day Pancreatic Cancer healthcare Paolo Tarantino AI radiation oncology cervical cancer IASLC WHO ASCO25 Zainab Shinkafi-Bagudu multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}